Tag Archives: UN

Top Cheap Stocks To Buy Right Now

“Prepaid wireless” hasn’t always carried the best reputation. Often, what leaps to mind is less-than-stellar coverage, cheap flip phones, or consumers with lousy credit.

MetroPCS is hoping to alter what it insists is an outdated perception with a name change announced Monday, coupled with two new tiered unlimited wireless plans that feature benefits through Amazon Prime and Google One.

Beginning Oct. 8, MetroPCS becomes Metro by T-Mobile, reflecting not only that the prepaid carrier has been owned by the nation’s No. 3 wireless provider since 2013 but that its customers get cell service from the very same network as regular T-Mobile customers and have access to top brand handsets, too, including the latest iPhones.

More: iPhone XS and XS Max review: Apple’s beautiful big-screen beasts exact a small ransom

Top Cheap Stocks To Buy Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Joseph Griffin]

    Stevens Capital Management LP bought a new stake in shares of SAGE Therapeutics Inc (NASDAQ:SAGE) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 3,223 shares of the biopharmaceutical company’s stock, valued at approximately $504,000.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

Top Cheap Stocks To Buy Right Now: OMNOVA Solutions Inc.(OMN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on OMNOVA Solutions (OMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    Get an exclusive invitation to meet Tim before everyone else right here.

    The Top Stock Market Stories for Wednesday
    The U.S. markets are preparing for the eighth interest rate hike since 2015, and the Federal Reserve may not be done yet. Markets are weighing the possibility that the Fed may raise rates one more time this year (in December). The hikes come as the Fed is attempting to shrink its $4.5 trillion balance sheet. When Powell speaks this afternoon, expect a few questions about the impact of the trade war between the United States and China. Reporters will also likely want to know about geopolitical risks to the U.S. economy and how they might affect growth in a higher-interest-rate environment. Yesterday, U.S. President Donald Trump gave a speech before the United Nations General Assembly. During his talk, Trump praised the U.S. economy and defended his administration’s actions this year on trade. Trump said that the United States will no longer endure “abuse” from other trade partners. The U.S. Trade Representative Robert Lighthizer also said Tuesday that the U.S. is prepared to proceed on a new trade deal with Mexico without the participation of Canada. Oil prices are in focus after President Trump called out OPEC members before the U.N. on Tuesday. During his talk, Trump accused OPEC and non-OPEC participants in collusion efforts on production and prices of ripping off the rest of the world.
    Three Stocks to Watch Today: NKE, SVMK, DB
    Shares of Nike Inc. (NYSE: NKE) fell 3.5% after the sports apparel giant reported earnings after the bell. The company topped earnings expectations and reported profit growth of 15%. However, investors took some profits off the table. Shares of Nike stock are up more than 35% on the year. SVMK, the parent company of SurveyMonkey, has priced its upcoming IPO at $12 per share. That figure is above analysts’ initial range expectation of $9 to $11 per share. The firm expects to reach a market capitalization of $1.46 bil

  • [By Joseph Griffin]

    OMNOVA Solutions Inc. (NYSE:OMN) – Analysts at KeyCorp issued their Q2 2019 earnings estimates for shares of OMNOVA Solutions in a report issued on Wednesday, February 6th. KeyCorp analyst M. Sison expects that the specialty chemicals company will post earnings per share of $0.17 for the quarter. KeyCorp also issued estimates for OMNOVA Solutions’ Q3 2019 earnings at $0.18 EPS.

  • [By Motley Fool Transcribing]

    OMNOVA Solutions (NYSE:OMN) Q3 2018 Earnings Conference CallSep. 26, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Motley Fool Staff]

    OMNOVA Solutions (NYSE:OMN) Q2 2018 Earnings Conference CallJun. 28, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Cheap Stocks To Buy Right Now: Unilever NV(UN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Wrapmanager Inc. grew its stake in shares of Unilever NV (NYSE:UN) by 28.5% in the second quarter, HoldingsChannel.com reports. The firm owned 5,291 shares of the company’s stock after buying an additional 1,173 shares during the quarter. Wrapmanager Inc.’s holdings in Unilever were worth $295,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Cullen Frost Bankers Inc. acquired a new stake in Unilever NV (NYSE:UN) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 5,972 shares of the company’s stock, valued at approximately $321,000.

  • [By John Ballard]

    There is a lot to like about Procter & Gamble (NYSE:PG) and Unilever (NYSE:UN). These companies make products that people all over the world use every day, and both are good dividend payers.

  • [By Ethan Ryder]

    ETRADE Capital Management LLC increased its holdings in Unilever (NYSE:UN) by 20.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,787 shares of the company’s stock after buying an additional 4,767 shares during the period. ETRADE Capital Management LLC’s holdings in Unilever were worth $1,567,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 High Tech Stocks To Own Right Now

A relative calm in global markets is at risk of ending abruptly as U.S. traders return from a market holiday to the sight of Italy’s government in full-blown political crisis.

Populist parties called for fresh elections after Italy’s president refused to endorse their choice of finance minister and appointed Carlo Cottarelli, a former International Monetary Fund official, as prime minister instead.

The political impasse in the third-largest euro-zone economy has sent yields on Italian two-year government bonds up by a whopping 202.4 basis points this month — the first monthly jump of over 100 basis points since May 2012, when Europe was enmeshed in the debt crisis that triggered existential questions about the single currency. While U.S. Treasury yields slipped some in Tuesday trading, broad measures of volatility remain a fraction of February highs.

#lazy-img-328105134:before{padding-top:56.25%;}

"The lack of an obvious solution to this impasse is troubling, especially given the size of Italy’s economy and debt stock," Morgan Stanley analysts including Andrew Sheets wrote in a note dated May 28. "Yet given the worry it’s causing, it’s notable what hasn’t moved."

Top 10 High Tech Stocks To Own Right Now: InterOil Corporation(IOC)

Advisors’ Opinion:

  • [By Shane Hupp]

    I/O Coin (CURRENCY:IOC) traded 26.1% higher against the US dollar during the one day period ending at 22:00 PM E.T. on August 17th. Over the last seven days, I/O Coin has traded up 50% against the US dollar. One I/O Coin coin can now be purchased for $0.39 or 0.00005901 BTC on exchanges. I/O Coin has a market capitalization of $6.55 million and approximately $14,268.00 worth of I/O Coin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Media headlines about InterOil (NYSE:IOC) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. InterOil earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news articles about the oil and gas company an impact score of 45.5148763796823 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 High Tech Stocks To Own Right Now: Koss Corporation(KOSS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
    CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
    Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
    Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
    Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
    Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
    Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
    Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
    Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

     

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

  • [By Money Morning Staff Reports]

    However, Seven Star’s gains are already on the books. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 70%…

    Penny Stock Current Share Price Last Week’s Gain
    Seven Stars Cloud Group Inc. (Nasdaq: SSC) $4.49 175.13%
    Alliance MMA Inc. (Nasdaq: AMMA) $0.37 121.05%
    India Globalization Capital Inc. (NYSE: IGC) $1.14 74.38%
    Obalon Therapeutics Inc. (Nasdaq: OBLN) $3.23 63.16%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.56 55.76%
    Atlanticus Holdings Corp. (Nasdaq: ATLC) $2.85 43.55%
    Research Frontiers Inc. (Nasdaq: REFR) $1.28 41.37%
    Koss Corp. (Nasdaq: KOSS) $4.08 41.28%
    GLG Life Tech Corp. (TSE: GLG) $0.88 33.90%
    Geron Corp. (Nasdaq: GERN) $4.76 32.40%

    While those gains are already in the book, you don’t have to miss out on the next penny stocks to soar.

Top 10 High Tech Stocks To Own Right Now: Unilever NV(UN)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    Procter & Gamble (NYSE:PG) and Unilever (NYSE:UL) (NYSE:UN) have long been the two companies that have most defined the household goods space, dominating categories like detergent, soap, deodorant, and condiments, to name only a few.

  • [By Shanthi Rexaline]

    Unilever NV (ADR) ADR (NYSE: UN) procures sustainable oils such as soy, sunflower and rapeseed oil for a host of its consumer products such as Hellmann's mayonnaise. It remains to be seen how the U.S.-China standoff will hurt its margins.

  • [By Joseph Griffin]

    Stepan (NYSE: SCL) and Unilever (NYSE:UN) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

  • [By Stephan Byrd]

    Guyasuta Investment Advisors Inc. raised its position in shares of Unilever NV (NYSE:UN) by 1.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 459,725 shares of the company’s stock after buying an additional 4,520 shares during the period. Unilever comprises about 2.9% of Guyasuta Investment Advisors Inc.’s holdings, making the stock its 9th largest holding. Guyasuta Investment Advisors Inc.’s holdings in Unilever were worth $25,616,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Unilever (NYSE:UN) has earned an average recommendation of “Hold” from the nine research firms that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company.

Top 10 High Tech Stocks To Own Right Now: Walker & Dunlop, Inc.(WD)

Advisors’ Opinion:

  • [By Dan Caplinger]

    For more than a decade, the real estate market has rebounded from the housing bust in the mid-2000s that led to the financial crisis. Since then, demand for both residential and commercial properties has been strong, and Walker & Dunlop (NYSE:WD) has capitalized by offering multiple methods of financing to real estate developers. Yet at long last, rising interest rates have started to raise concerns among real estate investors that the long bull market in the asset class could finally come to an end.

  • [By Ethan Ryder]

    Walker & Dunlop, Inc. (NYSE:WD) – Equities research analysts at Wedbush raised their Q1 2019 earnings estimates for shares of Walker & Dunlop in a report released on Monday, February 11th. Wedbush analyst H. Coffey now forecasts that the financial services provider will post earnings of $1.05 per share for the quarter, up from their previous forecast of $0.99. Wedbush has a “Outperform” rating and a $58.00 price objective on the stock. Wedbush also issued estimates for Walker & Dunlop’s Q2 2019 earnings at $1.26 EPS, Q3 2019 earnings at $1.53 EPS, Q4 2019 earnings at $1.56 EPS, FY2019 earnings at $5.40 EPS and FY2020 earnings at $5.95 EPS.

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Micron Technology (NASDAQ:MU), and Walker & Dunlop (NYSE:WD) actually have relatively low valuations. Here’s why these are three bargain stocks you can buy right now. 

  • [By Logan Wallace]

    Boston Partners increased its holdings in Walker & Dunlop, Inc. (NYSE:WD) by 3.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,495,943 shares of the financial services provider’s stock after buying an additional 45,657 shares during the period. Boston Partners owned about 4.82% of Walker & Dunlop worth $83,249,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 High Tech Stocks To Own Right Now: Imperial Oil Limited(IMO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Imperial Oil Ltd (NYSEAMERICAN:IMO) (TSE:IMO) saw a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 11,491,321 shares, an increase of 1.1% from the May 31st total of 11,363,187 shares. Based on an average trading volume of 400,912 shares, the days-to-cover ratio is presently 28.7 days.

  • [By Shane Hupp]

    Swiss National Bank cut its position in shares of Imperial Oil (NYSEAMERICAN:IMO) (TSE:IMO) by 6.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,066,300 shares of the energy company’s stock after selling 76,100 shares during the period. Swiss National Bank owned approximately 0.13% of Imperial Oil worth $28,203,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Citadel Advisors LLC purchased a new stake in shares of Imperial Oil Ltd (NYSEAMERICAN:IMO) (TSE:IMO) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 44,728 shares of the energy company’s stock, valued at approximately $1,487,000.

Top 10 High Tech Stocks To Own Right Now: 1-800 FLOWERS.COM Inc.(FLWS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on 1-800-Flowers.Com (FLWS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    1-800-Flowers.Com (NASDAQ:FLWS)‘s stock had its “buy” rating restated by analysts at Benchmark in a research note issued on Wednesday, Marketbeat.com reports. They presently have a $16.00 price objective on the specialty retailer’s stock, up from their previous price objective of $14.00. Benchmark’s price objective would suggest a potential upside of 26.28% from the company’s previous close.

  • [By Motley Fool Transcribers]

    1-800-Flowers.com Inc (NASDAQ:FLWS)Q4 2018 Earnings Conference CallAug. 23, 2018, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 High Tech Stocks To Own Right Now: Prudential Public Limited Company(PUK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Prudential Public Limited (NYSE:PUK) has earned a consensus recommendation of “Hold” from the six analysts that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company.

  • [By Ethan Ryder]

    Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

  • [By Ethan Ryder]

    ValuEngine lowered shares of Prudential (NYSE:PUK) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning.

    Several other analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Prudential from a hold rating to a buy rating and set a $57.00 target price on the stock in a research note on Tuesday, March 27th. Berenberg Bank cut shares of Prudential from a hold rating to a sell rating in a research note on Thursday, March 29th. Finally, Citigroup cut shares of Prudential from a buy rating to a neutral rating in a research note on Wednesday, April 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The stock currently has an average rating of Hold and an average price target of $57.00.

  • [By Stephan Byrd]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Prudential alerts:

    Zacks Investment Research Lowers Prudential (PUK) to Hold (americanbankingnews.com) Financial wellness program popularity rises among employers, up 63 percentage points in two years (markets.financialcontent.com) FY2018 EPS Estimates for Prudential (PUK) Reduced by Jefferies Group (americanbankingnews.com) Jefferies Group Weighs in on Prudential’s FY2020 Earnings (PUK) (americanbankingnews.com) ValuEngine Downgrades Prudential (PUK) to Hold (americanbankingnews.com)

    Shares of PUK stock traded down $0.02 during trading on Tuesday, hitting $51.56. 141,455 shares of the stock traded hands, compared to its average volume of 198,097. The firm has a market cap of $66.49 billion, a PE ratio of 13.79, a PEG ratio of 1.34 and a beta of 1.55. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.03 and a current ratio of 0.03. Prudential has a 52-week low of $44.49 and a 52-week high of $55.36.

Top 10 High Tech Stocks To Own Right Now: ThyssenKrupp AG (TYEKF)

Advisors’ Opinion:

  • [By ]

    United Technologies’ Otis division manufactures and services elevators, escalators, and other people moving devices. The business is reasonably attractive since there is a fair degree of concentration. Four major companies, Kone Oyj (OTCPK:KNYJF) (OTCPK:KNYJY), ThyssenKrupp (OTCPK:TYEKF) (OTCPK:TKAMY), Schindler (OTCPK:SHLAF) (OTC:SHNDY), and Otis, account for over 50% market share. The main long-term drivers of the industry are urbanization. As you might guess, elevator demand is strongest in dense urban environments where almost every building is multi-story.

Top 10 High Tech Stocks To Own Right Now: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ultragenyx launched its second drug, Crysvita, in the United States to treat X-linked hypophosphatemia (XLH) in April. We are optimistic on the drug’s uptake. The drug was also approved in the EU in February on a conditional basis. In May, the company announced positive phase II data from the drug in pediatric setting, but according to the FDA those were not sufficient to support an NDA. Thus, the company is in discussions with FDA and EMA, which would provide further clarity regarding whether an additional study would be required for the approval. The company also remains focused on its two-gene therapy programs — DTX301 for ornithine transcarbamylase deficiency and DTX401 for glycogen storage disease type Ia. However, developmental or regulatory setbacks could result in higher operating expenses and the need for additional capital. Loss estimates have narrowed ahead of  Q3 earnings release.”

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ultragenyx Pharmaceutical (RARE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is expected to report Phase 2 data from all its tumor-induced osteomalacia patients. Shares of Ultragenyx closed Friday at $76.87, in a 52-week range of $41.67 to $86.10 and with a consensus analyst target of $68.74.

  • [By Shane Hupp]

    These are some of the media headlines that may have effected Accern’s scoring:

    Get Ultragenyx Pharmaceutical alerts:

    Burosumab Improves Outcomes in Children with XLH in Phase 2 Trial (raredr.com) RARE Stock Is on the Verge of Breaking Out Toward Higher Prices (profitconfidential.com) Burosumab may benefit children with X-linked hypophosphatemia (medicalxpress.com) A Look Inside the Quant Data For Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) (parkcitycaller.com) Ultragenyx Pharmaceutical Inc. (RARE)- Stock in the Trader’s Radar (nasdaqfortune.com)

    A number of research firms have recently weighed in on RARE. ValuEngine raised Ultragenyx Pharmaceutical from a “hold” rating to a “buy” rating in a report on Saturday. BidaskClub raised Ultragenyx Pharmaceutical from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Barclays raised Ultragenyx Pharmaceutical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $62.00 to $74.00 in a report on Friday, May 11th. Goldman Sachs Group began coverage on Ultragenyx Pharmaceutical in a report on Thursday, May 10th. They set a “neutral” rating and a $63.00 target price for the company. Finally, Zacks Investment Research downgraded Ultragenyx Pharmaceutical from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $70.06.

  • [By Motley Fool Transcribers]

    Ultragenyx Pharmaceutical Inc  (NASDAQ:RARE)Q4 2018 Earnings Conference CallFeb. 19, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) from a hold rating to a buy rating in a report released on Monday.

    A number of other brokerages have also recently weighed in on RARE. JPMorgan Chase restated an overweight rating and issued a $66.00 price objective (down from $68.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. Evercore ISI upgraded shares of Ultragenyx Pharmaceutical from an in-line rating to an outperform rating in a research note on Monday, January 22nd. Stifel Nicolaus restated a buy rating and issued a $74.00 price objective (down from $85.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. ValuEngine upgraded shares of Ultragenyx Pharmaceutical from a sell rating to a hold rating in a research note on Wednesday, April 4th. Finally, Wedbush reiterated a positive rating and set a $71.00 target price (up from $64.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Ultragenyx Pharmaceutical presently has a consensus rating of Buy and an average price target of $69.76.

Top 10 High Tech Stocks To Own Right Now: GWG Holdings, Inc(GWGH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Here are some of the news articles that may have effected Accern Sentiment’s analysis:

    Get GWG alerts:

    Critical Review: Citizens (CIA) vs. GWG (GWGH) (americanbankingnews.com) (Watch) Zibanejad scores in Sweden’s win over Russia (sny.tv) GWG Holdings’ (GWGH) CEO Jon Sabes on Q1 2018 Results – Earnings Call Transcript (msn.com) Edited Transcript of GWGH earnings conference call or presentation 14-May-18 8:30pm GMT (finance.yahoo.com) DWWA judge profile: Davide Buongiorno (decanter.com)

    A number of equities research analysts recently commented on the company. Zacks Investment Research raised GWG from a “hold” rating to a “buy” rating and set a $9.25 price target for the company in a research report on Wednesday, April 11th. ValuEngine lowered GWG from a “hold” rating to a “sell” rating in a research report on Monday, May 14th. Finally, Maxim Group reaffirmed a “buy” rating and set a $14.00 target price on shares of GWG in a research report on Tuesday, January 23rd.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks For 2019

Quorum Health (NYSE: QHC) and Tenet Healthcare (NYSE:THC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.

Institutional and Insider Ownership

Get Quorum Health alerts:

85.3% of Quorum Health shares are owned by institutional investors. 4.7% of Quorum Health shares are owned by insiders. Comparatively, 1.2% of Tenet Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Quorum Health and Tenet Healthcare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Quorum Health -9.14% -46.79% -2.65%
Tenet Healthcare -2.90% 23.13% 0.71%

Analyst Recommendations

Top Medical Stocks For 2019: Vera Bradley Inc.(VRA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Tandy Leather Factory (NASDAQ: TLF) and Vera Bradley (NASDAQ:VRA) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

  • [By Garrett Baldwin]

    Markets are cheering a major development in efforts to fix the ongoing trade conflict between the United States and China. According to Reuters, Chinese telecom giant ZTE has signed an agreement to get back into business with its American partners. The agreement will lift a ban by the U.S. Commerce Department that prevented China’s No. 2 telecommunications equipment from buying from U.S. suppliers. This is a major development, and one that signals progress among trade officials from both nations. There are now more job openings in the United States than available workers. This is the first time that the Department of Labor has documented this phenomenon. There are 6.7 million openings compared to the 6.4 million workers available to fill those positions. As a result, U.S. companies have been forced to increase compensation in order to attract talent. All of the positive economic development could come to a screeching halt should the U.S. experience the largest labor strike in a decade. Reports indicate that the Teamsters and the United Parcel Service (NYSE: UPS) are on a collision course that could result in a general strike. The union has announced that 260,000 UPS employees have authorized a strike should both sides fail to reach a labor deal by August 1. UPS is responsible for the transport of 6% of the nation’s gross domestic product.
    Three Stocks to Watch Today: TSLA, NOG, WFC
    Tesla Inc. (Nasdaq: TSLA) investors remain committed to giving Chairman Elon Musk more of their money. On Tuesday, shareholders struck down proposals that would have removed Musk from the chairman role and shaken up the board of directors. Both proposals failed. At the same shareholder event, Musk announced plans for Tesla to open a production facility in Shanghai and projected that his firm will likely produce 5,000 Model 3 vehicles per week by the end of June. In deal news, defense contractor Northrop Grumman (NYSE: NOG) has won U.S. antitrust approval to purchase rocket moto

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Vera Bradley (VRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Vera Bradley (NASDAQ:VRA) reached a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $13.30 and last traded at $13.16, with a volume of 54803 shares traded. The stock had previously closed at $12.72.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Vera Bradley (VRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Wells Fargo & Company MN lifted its holdings in shares of Vera Bradley (NASDAQ:VRA) by 25.0% in the fourth quarter, Holdings Channel reports. The fund owned 29,830 shares of the textile maker’s stock after acquiring an additional 5,966 shares during the period. Wells Fargo & Company MN’s holdings in Vera Bradley were worth $363,000 as of its most recent filing with the Securities and Exchange Commission.

Top Medical Stocks For 2019: Unilever NV(UN)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Unilever NV (ADR) ADR (NYSE: UN) procures sustainable oils such as soy, sunflower and rapeseed oil for a host of its consumer products such as Hellmann's mayonnaise. It remains to be seen how the U.S.-China standoff will hurt its margins.

  • [By Isaac Pino, CPA]

    If you’re an investor in consumer goods giant Unilever (NYSE:UN), odds are you followed the takeover bid from Kraft Heinz(NASDAQ: KHC) closely in 2017. Ultimately, it fell through, with Unilever’s management rebutting that it was better off on its own. There was some mustard left on the face of Kraft Heinz, but major shareholder Warren Buffett claimed there was potentially a misunderstanding of the nature of the offer. It was not intended to be a hostile takeover, he said, but it could have been perceived that way by Unilever.

  • [By Ethan Ryder]

    ETRADE Capital Management LLC increased its holdings in Unilever (NYSE:UN) by 20.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,787 shares of the company’s stock after buying an additional 4,767 shares during the period. ETRADE Capital Management LLC’s holdings in Unilever were worth $1,567,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By ]

    A company like Procter & Gamble, Unilever NV (UN) , CVS Health Corp. (CVS) or Walgreens Boots Alliance Inc. (WBA) might be interested in the Pfizer business, said Anthony Chambers, a director in the life sciences practice of consulting firm West Monroe Partners.

Top Medical Stocks For 2019: FBR & Co(FBRC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about FBR & Co (NASDAQ:FBRC) have been trending somewhat positive this week, according to Accern. Accern rates the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. FBR & Co earned a news impact score of 0.14 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 44.0509600232626 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top Medical Stocks For 2019: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

  • [By Stephan Byrd]

    American Century Companies Inc. grew its holdings in shares of Trueblue Inc (NYSE:TBI) by 24.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 95,307 shares of the business services provider’s stock after purchasing an additional 18,680 shares during the period. American Century Companies Inc. owned approximately 0.23% of Trueblue worth $2,468,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Trueblue (TBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

  • [By Logan Wallace]

    Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top Medical Stocks For 2019: P.T. Telekomunikasi Indonesia Tbk.(TLK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the telecommunication services shares climbed 1.18 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 7 percent, and Telekomnks Indn Prsr Tbk Prshn Prsrn-ADR (NYSE: TLK), up 3 percent.

  • [By Max Byerly]

    Telekomnks Indn Prsr Tbk Prshn Prsrn (NYSE:TLK) was upgraded by equities research analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

  • [By Anders Bylund]

    Telekomunikasi Indonesia (NYSE:TLK), the largest telecommunications company in Indonesia, reported first-quarter results on Tuesday, May 2. Top-line sales rose modestly in the first quarter thanks to higher wireless subscriber counts and a healthy broadband business, but those upsides had to overcome a substantial headwind from a mass exodus of old-school wireline subscribers.

Top 10 Medical Stocks To Own Right Now

Contrary to popular belief, hemp and marijuana aren’t the same thing. The difference between hemp and marijuana is primarily the amount of tetrahydrocannabinol (or THC), or is the primary psychoactive chemical in marijuana. Hemp contains less than 0.5% THC, while marijuana consists of anywhere from 6 % to 20% (and sometimes more) THC.

Granted, it’s not always a fully-appreciated distinction. Even though the federal government accurately recognizes that hemp and marijuana are only variants of the same species, Cannabis sativa, the DEAdoesn’t necessarily enforce its drug laws as such. For legitimate medical purposes, the government is perfectly willing to leave the matter alone.

The good news is, governments – federal as well as state – are finally starting to figure out the distinct differences between marijuana and hemp, and that bodes well for a young and hungry startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).

Top 10 Medical Stocks To Own Right Now: SPDR Wells Fargo Preferred Stock ETF (PSK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI holds five other SSgA fixed income ETFs, including the SPDR Wells Fargo Preferred Stock ETF (NYSE: PSK). PSK is DWFI's largest holding at a weight of 25.2 percent. DWFI's second-largest holding is an allocation of almost 25 percent to the SPDR Nuveen Barclays Municipal Bond ETF (NYSE: TFI).

Top 10 Medical Stocks To Own Right Now: Investment Technology Group, Inc.(ITG)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Investment Technology Group Inc. (NYSE: ITG) was downgraded to Market Perform from outperform by KeefeBruyette & Woods.

    Liquidity Services Inc. (NASDAQ: LQDT) was raised to Buy from Underperform, and the price target was raised up to $45 from $28.50, at Merrill Lynch.

Top 10 Medical Stocks To Own Right Now: Manitex International Inc.(MNTX)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrial shares fell by 0.08 percent. Meanwhile, top losers in the sector included Accenture Plc (NYSE: ACN), down 4 percent, and Manitex International Inc (NASDAQ: MNTX), down 4 percent.

Top 10 Medical Stocks To Own Right Now: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Rofin-Sinar Technologies (NASDAQ: RSTI) got a boost, shooting up 37 percent to $31.50 as Coherent, Inc. (NASDAQ: COHR) announced its plans to buy Rofin-Sinar Technologies Inc in a deal valued at around $942 million.

Top 10 Medical Stocks To Own Right Now: 8×8 Inc(EGHT)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of 8×8 (NASDAQ:EGHT) rose 26.6% in 2016, according to data from S&P Global Market Intelligence.

    So what

    The provider of internet-based voice and communications services put together a remarkable financial record last year. 8X8 beat Wall Street’s earnings and sales estimates handily in each one of the year’s quarterly reports,citing strong organic revenue growth among larger customers along the way. Large-scale corporate customers accounted for 53% of the company’s total sales in the recently reported second quarter, and these big clients are also showing strong loyalty to the 8×8 brand by renewing their service contracts.

  • [By Peter Graham]

    A long term performance chart shows small cap magicJack VocalTec Ltd underperforming versus VOIP related peers Vonage Holdings Corp (NYSE: VG)and 8×8, Inc (NASDAQ: EGHT) which have been volatile, but have been heading higher:

  • [By Peter Graham]

    A long term performance chart shows small cap magicJack VocalTec Ltd hitting lower highs and lowerlows for some years now but also leveling off while VOIP related peers Vonage Holdings Corp (NYSE: VG)and 8×8, Inc (NASDAQ: EGHT) have been volatile, but also largely heading higher:

  • [By Lisa Levin]

    Telecommunications services shares climbed 0.56 percent in trading on Thursday. Meanwhile, top gainers in the sector included Frontier Communications Corp (NASDAQ: FTR), and 8×8, Inc. (NASDAQ: EGHT).

Top 10 Medical Stocks To Own Right Now: Ashford Hospitality Trust Inc(AHT)

Advisors’ Opinion:

  • [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)

     

Top 10 Medical Stocks To Own Right Now: RELM Wireless Corporation(RWC)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested shorting small cap wireless communications manufacturer RELM Wireless Corporation (NYSEMKT: RWC):

Top 10 Medical Stocks To Own Right Now: Zimmer Biomet Holdings, Inc.(ZBH)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Focused Investors LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Focused+Investors+LLC

    These are the top 5 holdings of Focused Investors LLCZimmer Biomet Holdings Inc (ZBH) – 1,433,300 shares, 6.32% of the total portfolio. Shares added by 23.22%CVS Health Corp (CVS) – 2,120,700 shares, 6.01% of the total portfolio. Shares added by 19.73%Johnson & Johnson (JNJ) – 1,285,900 shares, 5.78% of the total portfolio. Shares reduced by 0.67%American Express Co (AXP) – 1,990,300 shares, 5.68% of the total portfolio. Shares reduced by 0.33%Anthem Inc (ANTM) – 944,800 shares, 5.64% of the total portfolio. Sh

  • [By Keith Speights]

    The three top dividend stocks in the dentistry industry are Patterson Companies (NASDAQ:PDCO), Zimmer Biomet Holdings (NYSE:ZBH), and Danaher (NYSE:DHR). But two of these, Zimmer Biomet and Danaher, pay out only small dividends.

Top 10 Medical Stocks To Own Right Now: Unilever NV(UN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, industrial shares fell by 0.04 percent. Meanwhile, top losers in the sector included Unilever N.V. (ADR) (NYSE: UN), down 8 percent, and Magal Security Systems Ltd. (USA) (NASDAQ: MAGS), down 6 percent.

  • [By Teresa Rivas]

    Earlier this year, Unilever (UN) recently declined Kraft Heinz (KHC) merger bid. That means that if the company still wants to do a deal, Mondelez International (MDLZ) and PepsiCo (PEP) are the next logical partners, writes Susquehannas Pablo Zuanic.

    Getty Images

    Zuanic upgraded Pepsi from Neutral to Positive today and raised his price target from $118 to $132. He writes that a Pepsi deal would have more strategic merits, hence his upgrade (as he emphasizes that not much has changed in terms of fundamentals for the firm).

    More detail from his note:

    With investors apparently seeing MDLZ as the next likely KHC target, and Coca-Cola (KO) the next Anheuser-Busch (BUD) target, PEP shares have lost visibility and now trade at a 25% discount to KO on apples-to-apples comps. We see value here, on franchise strength, efforts to align the F&B portfolio with consumer health trends, and the growing optionality value of a joint KHC/BUD bid for PEP. We argue that, together, the Kendall Jenner commercial, the Aspartame to-be-or-not-to-be zigzagging, the new, new, new alt low-cal cola (Pepsi Zero sugar), the ongoing underperformance in U.S. CSDs (25% only of the company), the lack of scale in non-CSD NARTDs vs. KO (other than Gatorade), and now talk of PEP buying Brazilian dairy company Vigor S.A. (a JBS subsidiary that would better fit KHC or ULVR), all paint a picture of a company still struggling to set a new direction (with all due respect). In this regard, we think PEP may be more vulnerable than MDLZ to a KHC bid (jointly done with BUD). We also see greater strategic fit for KHC with PEP Food/Snacks (than with MDLZ), and argue that PEP Beverages fits BUD better than KO, as the PEP bottling operations in key regions (including NA) remain in the hands of PEP (KO, on the other hand will be fully refranchised by end of 2017). So we are upgrading PEP to Positive with a $132 price target by December 17. Yes, the Unilever rebuff

Top 10 Medical Stocks To Own Right Now: Bank Of Montreal(BMO)

Advisors’ Opinion:

  • [By Mitchell Clark]

     Banks can produce solid earnings growth in the early stages of a rising interest rate environment. This Canadian bank is not expensively priced on the stock market. It currently has an over four percent dividend yield.

    The Canadian banking market is small, but it’s protected from foreign ownership and most of the names in this industry have great long-term track records on the stock market.

direct investment

Many gold mining stocks have global footprints or have operations/exploration projects in countries that most investors would have trouble finding on a map. However, that may not be necessary as there are two good reasons to be looking atgold and domestic gold miners right now:

Donald Trump appears serious about trying to de-regulate and undo many Obama era regulations (especially on mining/natural resources) in order tomake it easier to produce new wealth. Gold is considered to be a safe haven and there is a certain level ofvolatility/uncertainty surrounding the Trump administration especially given the fact that he has plenty of enemies among the establishment and the media whofeel threatened by him.

As its name implies, small cap US Gold Corp (NASDAQ: USAU) is one suchUS focused gold exploration company worth taking a closer look at since its at an stage where there could be significant upside potential as its advances high potential projects in Nevada and Wyoming. The Companys current properties offer high upside due to large growth potential for the current resource and valuation upside based on market comps:

direct investment: Visteon Corporation(VC)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Visteon (VC) : “You need to let this one come down a little, then pull the trigger.”

    American Tower (AMT) : “This is the best in the business and is worth owning, even if the chart looks terrible.”

  • [By WWW.GURUFOCUS.COM]

    For the details of Solus Alternative Asset Management LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Solus+Alternative+Asset+Management+LP

    These are the top 5 holdings of Solus Alternative Asset Management LPC&J Energy Services Inc (CJ) – 7,553,128 shares, 48.21% of the total portfolio. Loral Space & Communications Inc (LORL) – 1,936,891 shares, 14.99% of the total portfolio. Shares reduced by 0.57%Visteon Corp (VC) – 633,018 shares, 12.03% of the total portfolio. Shares reduced by 22.88%Peabody Energy Corp (BTU) – 2,160,564 shares, 9.84% of the total portfolio. New PositionDynegy Inc (DYN) – 3,022,583 shares, 4.66%

direct investment: Unilever NV(UN)

Advisors’ Opinion:

  • [By Teresa Rivas]

    Earlier this year, Unilever (UN) recently declined Kraft Heinz (KHC) merger bid. That means that if the company still wants to do a deal, Mondelez International (MDLZ) and PepsiCo (PEP) are the next logical partners, writes Susquehannas Pablo Zuanic.

    Getty Images

    Zuanic upgraded Pepsi from Neutral to Positive today and raised his price target from $118 to $132. He writes that a Pepsi deal would have more strategic merits, hence his upgrade (as he emphasizes that not much has changed in terms of fundamentals for the firm).

    More detail from his note:

    With investors apparently seeing MDLZ as the next likely KHC target, and Coca-Cola (KO) the next Anheuser-Busch (BUD) target, PEP shares have lost visibility and now trade at a 25% discount to KO on apples-to-apples comps. We see value here, on franchise strength, efforts to align the F&B portfolio with consumer health trends, and the growing optionality value of a joint KHC/BUD bid for PEP. We argue that, together, the Kendall Jenner commercial, the Aspartame to-be-or-not-to-be zigzagging, the new, new, new alt low-cal cola (Pepsi Zero sugar), the ongoing underperformance in U.S. CSDs (25% only of the company), the lack of scale in non-CSD NARTDs vs. KO (other than Gatorade), and now talk of PEP buying Brazilian dairy company Vigor S.A. (a JBS subsidiary that would better fit KHC or ULVR), all paint a picture of a company still struggling to set a new direction (with all due respect). In this regard, we think PEP may be more vulnerable than MDLZ to a KHC bid (jointly done with BUD). We also see greater strategic fit for KHC with PEP Food/Snacks (than with MDLZ), and argue that PEP Beverages fits BUD better than KO, as the PEP bottling operations in key regions (including NA) remain in the hands of PEP (KO, on the other hand will be fully refranchised by end of 2017). So we are upgrading PEP to Positive with a $132 price target by December 17. Yes, the Unilever rebuff

  • [By Lisa Levin]

    In trading on Tuesday, industrial shares fell by 0.04 percent. Meanwhile, top losers in the sector included Unilever N.V. (ADR) (NYSE: UN), down 8 percent, and Magal Security Systems Ltd. (USA) (NASDAQ: MAGS), down 6 percent.

direct investment: North American Energy Partners, Inc.(NOA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, energy shares slipped by 1.36 percent. Meanwhile, top losers in the sector included Northern Oil & Gas, Inc. (NYSE: NOG), down 9 percent, and North American Energy Partners Inc.(USA) (NYSE: NOA), down 6 percent.

direct investment: Cotiviti Holdings, Inc. (COTV)

Advisors’ Opinion:

  • [By Scott Rubin]

    Big gainers on the day included Intersil Corp (NASDAQ: ISIL), which jumped 20 percent on news of a buyout, and Medivation (NASDAQ: MDVN), which added 20 percent on a deal with Pfizer (NYSE: PFE) related to its cancer drug. Cotiviti Holdings Inc (NYSE: COTV) lost around 9 percent in the wake of a mid-day sell-off and Marathon Oil Corporation (NYSE: MRO) fell 7 percent in the wake of a management shakeup.